Real-World Treatment Patterns in Patients With Metastatic Castration-Resistant Prostate Cancer in Greece: The PROSPECT Study.

M LiontosE BournakisA BournakisE KostourosV ZolotaA P PapatheodoridiK KaralisA KyriazoglouR ZakopoulouE VasiliA TzovarasI DimitriadisG EmmanouilD MauriC ChristodoulouM TsiatasF ZagouriA Bamias

Published in: Clinical genitourinary cancer (2024)

Most patients were treated with 1L NHAs, in accordance to established guidelines (which suggest both NHA and chemo as preferred 1st line options). There appeared to be a longer time on treatment of NHAs at 1L than chemotherapy, suggesting an unmet need for treatment optimisation/recommendations for 2L and 3L treatment in mCRPC.

Keyphrases

end stage renal disease
newly diagnosed
radiation therapy
photodynamic therapy
peritoneal dialysis
ejection fraction
clinical practice
replacement therapy
patient reported outcomes